AXSM FY 2015 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AXSMAxsome Therapeutics, Inc.

$8B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3,542

Operating Income

-$9M

Net Income

-$12M

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$803,279

Balance Sheet

Total Assets

$49M

Total Liabilities

$3M

Stockholders' Equity

$46M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3,542	$0	—
Operating Income	-$9M	-$6M	-62.1%
Net Income	-$12M	-$6M	-103.5%